France
KerNel Biomedical, founded in 2016, is an independent laboratory based in France specializing in the bench testing of respiratory assistance medical devices. With a focus on innovation in respiratory assistance, the company leverages its expertise in modeling and signal processing to assess various medical devices including home and intensive care ventilators, CPAP devices, and oxygen therapy solutions. They utilize realistic physiopathological models for both regulatory and R&D purposes, aiming to enhance product reliability and efficacy.
Known for developing sophisticated algorithms and software solutions for data processing in the biomedical sector, KerNel Biomedical also supports clinical research database management. The firm's innovative approach is evidenced by its recognition as a Young Innovative Company (JEI) and its attainment of the Research Accreditation (CIR). With methodologies published in peer-reviewed journals, their credibility in the field is well-established. Investors should note their last known investment from Normandie Incubation occurred in 2018, underscoring the opportunity for potentially untapped investment as they continue to play a significant role in biotechnology and medical analytics.
